$Amazing $Biotech & $olid $Microcap $tocks

[ash111]

SRNE LPCN APRI (MC, Cash, Assets/liabilities ratio, S-3 Comparison):

SRNE-
MC $214,312,154
Cash, Past 10Q: $58m
T.Assets/T.liabilities Ratio 1.3
Outstanding Shares 76,540,055 a/o Jul 27, 2017

LPCN-
MC $76,695,005
Cash, Past 10Q: $27.8m
T.Assets/T.liabilities Ratio 9.6
Outstanding Shares 20,672,508 a/o Aug 04, 2017

APRI-
MC $23,266,445
Cash, Past 10Q: $8.8m
T.Assets/T.liabilities Ratio 4
Outstanding Shares 12,783,761 a/o Jul 28, 2017


SRNE Oct 5, 2017, S-3: up to 754,930 shares of our common stock.

LPCN Oct. 13, 2017, S-3: $150M mixed shelf offering.

APRI Sept 25, 2017, S-3: up to 3,311,752 Shares of our common stock.